Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.58 USD | +2.39% | +0.10% | -28.81% |
03-06 | Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating | MT |
02-29 | UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating | MT |
Evolution of the average Target Price on Fulgent Genetics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Fulgent Genetics, Inc.
Piper Sandler | |
UBS | |
Credit Suisse | |
Raymond James | |
Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- FLGT Stock
- Consensus Fulgent Genetics, Inc.